View in EDS

Optimizing communication for ultrafast lung cancer biomarker testing: the UTOPIA pilot study.

Saved in:
Bibliographic Details
Title: Optimizing communication for ultrafast lung cancer biomarker testing: the UTOPIA pilot study.
Authors: Hernandez S; Department of Pathology, Hospital Universitario 12 de Octubre, Molecular and Computational Pathology Group, Research Institute Hospital 12 de Octubre (imas12), Madrid, Spain., Conde E; Department of Pathology, Hospital Universitario 12 de Octubre, Universidad Complutense de Madrid, Molecular and Computational Pathology Group, Research Institute Hospital 12 de Octubre (imas12) , CIBERONC, Madrid, Spain., Alonso M; Department of Pathology, Hospital Universitario 12 de Octubre, Molecular and Computational Pathology Group, Research Institute Hospital 12 de Octubre (imas12), Madrid, Spain., Curto D; Department of Pathology, Hospital Universitario 12 de Octubre, Molecular and Computational Pathology Group, Research Institute Hospital 12 de Octubre (imas12), Madrid, Spain., Duran F; Department of Pathology, Hospital Universitario 12 de Octubre, Madrid, Spain., Ast A; Skidmore College, Saratoga Springs, United States., Torres-Jimenez J; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Research Institute Hospital 12 de Octubre (imas12), Madrid, Spain., Cabo HB; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Research Institute Hospital 12 de Octubre (imas12), Madrid, Spain., Zurera M; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Research Institute Hospital 12 de Octubre (imas12), Madrid, Spain., Baena J; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Research Institute Hospital 12 de Octubre (imas12), Madrid, Spain., Zugazagoitia J; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Research Institute Hospital 12 de Octubre (imas12), CIBERONC, Madrid, Spain., Garcia-Lujan R; Department of Pulmonology, Endoscopic Respiratory Unit, Hospital Universitario 12 de Octubre, Madrid, Spain., Isla D; Department of Medical Oncology, Hospital Universitario Lozano Blesa, Zaragoza, IIS Aragon, Spain., Castro J; Department of Medical Oncology, Hospital Universitario La Paz, Research Institute IdiPAZ, Madrid, Spain., Paz-Ares L; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Universidad Complutense de Madrid, Research Institute Hospital 12 de Octubre (imas12), CIBERONC, Madrid, Spain., Lopez-Rios F; Department of Pathology, Hospital Universitario 12 de Octubre, Universidad Complutense de Madrid, Molecular and Computational Pathology Group, Research Institute Hospital 12 de Octubre (imas12) , CIBERONC, Madrid, Spain. Electronic address: fernandolopezriosmoreno@gmail.com.
Source: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2026 Jan; Vol. 211, pp. 108887. Date of Electronic Publication: 2025 Dec 23.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8332 (Electronic) Linking ISSN: 01695002 NLM ISO Abbreviation: Lung Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1872-8332
DOI:10.1016/j.lungcan.2025.108887